OM336 in Seropositive Autoimmune Diseases
NCT07229144
·
clinicaltrials.gov ↗
PHASE1
Phase
NOT_YET_RECRUITING
Status
39
Enrollment
INDUSTRY
Sponsor class
Conditions
Sjogrens Disease
Idiopathic Inflammatory Myopathy (IIM)
Interventions
DRUG:
OM336
Sponsor
Ouro Medicines